BOSTON, Aug 21 (Reuters) - Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said on Tuesday it has filed for U.S. approval to sell its antidepressant Cymbalta as a treatment for the pain condition fibromyalgia.
BOSTON, Aug 21 (Reuters) - Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said on Tuesday it has filed for U.S. approval to sell its antidepressant Cymbalta as a treatment for the pain condition fibromyalgia.
